Open AccessEfficacy and Safety of Bevacizumab-Combined Chemotherapy for Advanced and Recurrent Endometrial Cancer: A Systematic Review and Meta-analysis
Author(s) -
Hui Chen,
Liang Mao,
Jie Min
Publication year - 2021
Publication title -
balkan medical journal/balkan medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 16
eISSN - 2146-3131
pISSN - 2146-3123
DOI - 10.5152/balkanmedj.2021.20121
Subject(s) - bevacizumab , medicine , endometrial cancer , oncology , hazard ratio , chemotherapy , leukopenia , meta analysis , progression free survival , surgery , cancer , confidence interval
Bevacizumab-combined chemotherapy is a new regimen for advanced/recurrent endometrial cancer.